TRINITY BIOTECH PLC (TRIB) Form 424B3 — Jun 23, 2026
Trinity Biotech plc filed a prospectus supplement for a secondary offering of up to 33,752,429 American Depositary Shares by selling shareholders, representing 675,048,580 Ordinary Shares. The ADSs are listed on Nasdaq under the symbol TRIB with a last reported sale price of $0.582 on June 22, 2026. The filing incorporates a Form 6-K announcing the launch of Trinovium, a subsidiary focused on advanced liquid cooling solutions for AI data centers. Trinovium aims to leverage Trinity's existing high-purity fluid manufacturing capacity to serve a market projected to grow from $4 billion to $27 billion by 2033.
Key figures
- Shares Offered
- 33752429
- Market cagr
- 31.5%
- Market size 2026
- $4 billion
- Market size 2033
- $27 billion
- Underlying shares
- 675048580
- Last reported sale price
- $0.582
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.